The Company reported worldwide first quarter revenue of $4.008 billion, an increase of 5 percent on a constant currency basis after adjusting for a $119 million negative foreign currency impact or 2 percent as reported. As reported, first quarter net earnings were $864 million, or $0.83 per diluted share...
People with blood type A, B, or AB had a higher risk for coronary heart disease when compared to those with blood type O, according to new research published in Arteriosclerosis, Thrombosis and Vascular Biology, an American Heart Association journal. People in this study with the rarest blood type -- AB, found in about 7 percent of the U.S. population...
Sound Interventions Updates Results From "SOUND-ITV" Trial Of Ultrasound-based Renal Denervation For Resistant HypertensionAugust 15, 2012 12:29 pm | by PRNewswire-USNewswire | News | Comments
Sound Interventions, Inc. today released three-month data from the company's First-In-Human clinical study (SOUND-ITV) to treat resistant hypertension through the use of catheter-based ultrasound. In addition to office-based blood pressure measurements, patients in the study underwent 24-hour Ambulatory Blood Pressure Monitoring...
Cook Medical’s Ongoing Zilver PTX Trial Data Show Higher Freedom From Target Lesion Revascularization (TLR) Rates Compared to Angioplasty and Bare Metal Stenting After Three YearsAugust 13, 2012 1:37 pm | News | Comments
Previously unreleased three-year data from the Zilver PTX Randomized Controlled Trial of Paclitaxel-Eluting Stents for Femoropopliteal Disease indicate that Cook Medical’s paclitaxel-eluting peripheral vascular stent demonstrated 83.0 percent freedom from TLR at 36 months in the PTX group...
American Heart Association Awarded $1.2M Grant from the Edwards Lifesciences Fund for Valvular Disease EducationAugust 8, 2012 9:53 am | News | Comments
The American Heart Association will launch a fully interactive valvular disease patient education center thanks to a grant from The Edwards Lifesciences Fund. The donor-advised fund will award $1.2 million to the American Heart Association over the next four years...
Implantable cardioverter defibrillators account for one-third of the decrease in cardiac arrests caused by ventricular fibrillation in North-Holland, according to research in Circulation, an American Heart Association journal.
There is a new solution of materials managers dealing with excess inventory. MDLMedical.com is a members-only, on-line exchange that helps hospitals and surgical centers buy and sell unused, new medical devices and implants; purchase needed inventory at market-determined prices and recover some of the costs of their idle surgical inventory.
BOSTON--(BUSINESS WIRE)--Aug 7, 2012--The Harvard Clinical Research Institute (HCRI) announced today the successful completion of randomization in the DAPT Study, with the total number of patients randomized exceeding the upper goal set for the Study. The DAPT Study is a four-year clinical trial...
Vascular Solutions, Inc. today announced that it has launched the SuperCross FT, a new flexible-tip version of its line of SuperCross microcatheters. SuperCross FT has been designed to address the majority of complex interventional procedures in which a flexible tipped microcatheter is needed.
An estimated 40% of healthcare equipment in developing countries is out of service, compared with less than 1% in high-income countries. The inappropriate deployment of medical technologies from wealthy countries plays a major part in this high failure rate.
A disturbing number of AEDs out there fail to do their job, or would fail if called upon to work.
Researchers in India have developed an improved expert system for the diagnosis of thyroid disease.
Groundbreaking report in Mayo Clinic Proceedings examines the implications of the Accountable Care Organization component of the Patient Protection and Affordable Care Act
Massachusetts lawmakers have given final approval to a bill designed to save up to $200 billion in health care costs over the next 15 years.
Bias may be completely unintentional, but everyone has it to one degree or another. It is the responsibility of ethical scientists to acknowledge those biases so that research data can be viewed more accurately and science is not slanted.
Medical devices save countless lives, but an interdisciplinary research team warns that federal regulators need to improve how they track security and privacy problems in medical devices.
The business, Exscien -- which in Latin means 'for science' -- was recently awarded a grant by the National Institutes of Health to support the development of a new drug aimed at preventing and reversing acute lung injury.
Medical and industrial equipment maker Roper Industries is buying hospital software company Sunquest Information Systems for approximately $1.42 billion.
Adult stem cells extracted during liposuction can be used to grow healthy new small-diameter blood vessels for use in heart bypass surgery and other procedures, according to new research presented at the American Heart Association's Basic Cardiovascular Sciences 2012 Scientific Sessions.
How are you influencing implantable devices?
SynCardia Systems, Inc., manufacturer of the world’s first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that Harvard-affiliated Brigham and Women’s Hospital in Boston has performed New England’s first implant of the SynCardia temporary Total Artificial Heart.
The U.S. Food and Drug Administration (FDA) has granted Cook Medical 510(k) clearance for the Evolution® Colonic Controlled-Release Stent, Cook announced today. The new stent expands Cook's line of Evolution controlled-release stents...
Flexible Stenting Solutions touts CE Mark approval for additional sizes of its FlexStent self-expanding iliac stents. FSS touts CE Mark win for new self-expanding stent sizes News Well, 510(k), CE Mark, Food & Drug Administration (FDA), Regulatory Roundup, Regulatory/Complianceread more
How are you influencing cardiovascular devices?
Ultrasonix Medical Corporation has received approval from the US Food and Drug Administration for its SonixGPS technology for Vascular Access procedures.